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Receptor editing: How B cells stay tolerant
In 1993, David Nemazee and Martin Weigert independently showed that 
autoreactive B cells could proofread, alter, and reexpress modified receptors 
to become nonautoreactive. This process, called “receptor editing,” has since 
gained prominence as the main mechanism of B cell tolerance.
The immune system generates a diverse 
army of T and B cells to deal with 
pathogen diversity but usually manages 
to exclude self-reactive cells from its 
repertoire. To explain this phenome-
non, McFarlane Burnet proposed the 
theory of clonal selection in 1959 (1). 
He hypothesized that cells that recog-
nized self-antigens would be killed 
during development. Only nonautore-
active cells would then enter circulation 
and be called upon to provide protec-
tion during immune responses. His 
model remained unchallenged until the 
late 1980s, when investigators found 
that some autoreactive B cells survived 
the purge but did not respond to anti-
genic stimulation (2). At the same time, 
David Nemazee, then an immunologist 
at the National Jewish Center in 
Denver, CO, found evidence for a 
third mechanism for tolerance.
By this time, the generation of 
receptor diversity in developing B cells 
had been well-characterized. Others 
had shown that recombinase proteins 
first rearrange the B cell’s heavy chain 
genes and then target the light chain 
genes. Checkpoints ensure that each B 
cell expresses only one receptor. It was 
therefore possible to force all the B cells 
in an animal model to express the same 
receptor by introducing prearranged 
antibody transgenes.
Death-defying B cells
Nemazee had been studying the dele-
tion of autoreactive B cells in trans-
genic mice whose B cells all expressed 
receptors specific for a particular MHC 
molecule. When this transgene was 
bred onto mice that expressed that 
MHC protein, the developing B cells 
recognized it as an autoantigen. As 
expected, these mice lacked autoreac-
tive B cells in the periphery. But to 
Nemazee’s surprise, a large pool of 
autoreactive B cells persisted in the 
bone marrow (3).
B cells repair their receptors
To pinpoint the exact step at which the 
cells were escaping deletion, Nemazee 
and his team engineered strains in 
which the autoantigen was targeted 
to different anatomical locations. Ex-
pression of autoantigen in just the 
liver caused a near complete deletion 
of anti-MHC B cells, which were not 
replaced by non-autoreactive coun-
terparts. Total B cell numbers were 
thus greatly reduced in the periphery. 
But when autoantigen was also pres-
ent in the bone marrow, there were 
many more peripheral B cells that 
were no longer self-reactive. Nemazee 
discovered that these cells had escaped 
by switching antibody receptors—they 
had new light chains derived from a 
rearranged version of the endogenous 
gene. The alterations took place in 
immature B cells, as Nemazee only 
detected the rearrangements in bone 
marrow B cells.
Light chain replacement was simul-
taneously demonstrated in a different 
transgenic model by Martin Weigert 
and his team at the Fox Chase Cancer 
Center (Philadelphia, PA). While 
studying lupus, Weigert had designed 
mice that carried a transgene for an 
anti-DNA antibody. He found that 
these mice lacked autoreactive DNA-
specific B cells. Younger mice had 
fewer B cells, suggesting that auto-
reactive clones had been deleted. But 
adult mice had normal numbers of B 
cells. These cells had substituted the 
transgene’s light chain with endoge-
nously rearranged light chains. Wei-
gert and Nemazee published their 
seminal results in a series of papers in 
the Journal of Experimental Medicine in 
1993 (4–6).
Improving on dogma
The studies were at first controversial, 
but numerous reports from other groups 
have since bolstered the case for recep-
tor editing as a major mechanism for 
tolerance (7). It is now estimated that at 
least 25% of B cells in the repertoire 
have undergone receptor editing (8). 
Nemazee’s anti-MHC transgenic 
mouse model has since been modified 
such that transgenes insert specifically 
into the heavy and light chain loci (9). 
These mice reveal that autoreactive 
B cells are rendered harmless mainly 
through receptor editing. Repairing its 
receptors rather than throwing away 
the whole cell might be the most effi-
cient way to generate a diverse, non-
self-reactive repertoire.
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